Moolec Science Bovine Myoglobin Pea Breakthrough
Analysis based on 6 articles · First reported Apr 07, 2026 · Last updated Apr 07, 2026
This scientific breakthrough by Moolec Science is expected to positively impact its stock price and market valuation, as it validates the scalability and versatility of its molecular farming platform. The successful expression of bovine myoglobin in pea seeds opens new pathways for scalable protein production, potentially disrupting the global food industry and attracting further investment in biotechnology and alternative protein sectors.
Moolec Science announced a significant scientific breakthrough on April 7, 2026, successfully demonstrating the stable expression of bovine myoglobin in pea seeds. This achievement, resulting from a 28-month sponsored research project with a leading U.S. academic institution, marks the first reported case of producing bovine myoglobin in pea seeds. The breakthrough expands Moolec Science's molecular farming platform beyond its current crop base, validating its proprietary constructs and reinforcing its ability to systematically expand across multiple crops. Alejandro Antalich, CEO of Moolec Science, highlighted this as a signal of the platform's scalability and versatility, crucial for long-term value creation for shareholders. The company, publicly listed on Nasdaq-100, believes this milestone further validates its patent portfolio and its applicability for large-scale deployment in food and biotechnology.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard